Ketamine used in the therapy of depressive disorders impacts protein profile, proliferation rate, and phagocytosis resistance of enterococci
Tomasz Jarzembowski
Department of Medical Microbiology, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Orcid-ProfilSuche nach diesem Autor auf
, Agnieszka Daca
Department of Pathology and Experimental Rheumatology, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Orcid-ProfilSuche nach diesem Autor auf
, Wiesław J. Cubała
Department of Psychiatry, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Orcid-ProfilSuche nach diesem Autor auf
, und 09. Aug. 2022
Über diesen Artikel
Artikel-Kategorie: Original Study
Online veröffentlicht: 09. Aug. 2022
Seitenbereich: 333 - 338
Eingereicht: 03. Jan. 2022
Akzeptiert: 11. Mai 2022
DOI: https://doi.org/10.2478/ahem-2022-0047
Schlüsselwörter
© 2022 Tomasz Jarzembowski et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Jarzembowski, Tomasz
Department of Medical Microbiology, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Daca, Agnieszka
Department of Pathology and Experimental Rheumatology, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Cubała, Wiesław J.
Department of Psychiatry, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Bronk, Marek
Department of Clinical Microbiology, Hospital of the Medical University of GdanskPoland
Naumiuk, Łukasz
Department of Clinical Microbiology, Hospital of the Medical University of GdanskPoland